McTiernan A - Search Results

1

A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.

McTiernan A, Meyer T, Michelagnoli MP, Lewis I, Whelan JS. McTiernan A, et al. Pediatr Blood Cancer. 2006 Mar;46(3):345-50. doi: 10.1002/pbc.20562. Pediatr Blood Cancer. 2006. PMID: 16206197 Clinical Trial.

2

A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma.

Janinis J, McTiernan A, Driver D, Mitchell C, Cassoni AM, Pringle J, Kilby A, Whelan JS; London Bone and Soft Tissue Tumour Service. Janinis J, et al. Among authors: mctiernan a. Ann Oncol. 2002 Dec;13(12):1935-44. doi: 10.1093/annonc/mdf338. Ann Oncol. 2002. PMID: 12453863 Free article.

3

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS. Strauss SJ, et al. Among authors: mctiernan a. J Clin Oncol. 2003 Aug 1;21(15):2974-81. doi: 10.1200/JCO.2003.04.106. J Clin Oncol. 2003. PMID: 12885818

4

Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours.

Whelan JS, McTiernan A, Kakouri E, Kilby A; London Bone and Soft Tissue Tumour Service. Whelan JS, et al. Among authors: mctiernan a. Pediatr Blood Cancer. 2004 Sep;43(3):237-42. doi: 10.1002/pbc.20107. Pediatr Blood Cancer. 2004. PMID: 15266407

5

Late relapse of osteosarcoma: implications for follow-up and screening.

Strauss SJ, McTiernan A, Whelan JS. Strauss SJ, et al. Among authors: mctiernan a. Pediatr Blood Cancer. 2004 Nov;43(6):692-7. doi: 10.1002/pbc.20154. Pediatr Blood Cancer. 2004. PMID: 15390283

6

High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.

McTiernan A, Driver D, Michelagnoli MP, Kilby AM, Whelan JS. McTiernan A, et al. Ann Oncol. 2006 Aug;17(8):1301-5. doi: 10.1093/annonc/mdl108. Epub 2006 Jun 16. Ann Oncol. 2006. PMID: 16782749 Free article.

7

A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma.

McTiernan A, Whelan J, Leahy M, Woll PJ. McTiernan A, et al. Sarcoma. 2006;2006(1):41080. doi: 10.1155/SRCM/2006/41080. Sarcoma. 2006. PMID: 17040090 Free PMC article.

8

Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution.

McTiernan AM, Cassoni AM, Driver D, Michelagnoli MP, Kilby AM, Whelan JS. McTiernan AM, et al. Sarcoma. 2006;2006:83548. doi: 10.1155/SRCM/2006/83548. Epub 2006 Nov 6. Sarcoma. 2006. PMID: 17496997 Free PMC article.

9

Experience of the use of trabectedin (ET-743, Yondelis) in 21 patients with pre-treated advanced sarcoma from a single centre.

Roylance R, Seddon B, McTiernan A, Sykes K, Daniels S, Whelan J. Roylance R, et al. Among authors: mctiernan a. Clin Oncol (R Coll Radiol). 2007 Oct;19(8):572-6. doi: 10.1016/j.clon.2007.05.006. Epub 2007 Jul 10. Clin Oncol (R Coll Radiol). 2007. PMID: 17624747 Clinical Trial.

10

A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours.

Meyer T, McTiernan A, Whelan J. Meyer T, et al. Among authors: mctiernan a. Sarcoma. 2003;7(1):13-7. doi: 10.1080/1357714031000114192. Sarcoma. 2003. PMID: 18521364 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters